Saltar al contenido
Merck

746452

Sulfato de magnesio

anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño



About This Item

Fórmula empírica (notación de Hill):
MgSO4
Número CAS:
Peso molecular:
120.37
NACRES:
NA.21
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
231-298-2
MDL number:
assay:
≥99.5%
grade:
anhydrous
form:
powder

Nombre del producto

Sulfato de magnesio, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%

InChI key

CSNNHWWHGAXBCP-UHFFFAOYSA-L

InChI

1S/Mg.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

SMILES string

[Mg++].[O-]S([O-])(=O)=O

grade

anhydrous

agency

suitable for SM 5210

vapor density

<0.01 (vs air)

vapor pressure

<0.1 mmHg ( 20 °C)

product line

ReagentPlus®
Redi-Dri

assay

≥99.5%

form

powder

quality

free-flowing

pH

~7.9 (25 °C, 50 g/L)

Quality Level

¿Está buscando productos similares? Visita Guía de comparación de productos

Application

Magnesium sulfate may be used as a drying agent for organic extracts.

Features and Benefits

  • Increased efficiency – Eliminate time and effort of loosening hardened powders
  • Safety – Avoid risks of using tools of force to break up clumps
  • Economy – Faster preparation and solvation increase productivity and reduce costs
  • Assured quality – Excellent, expert-tested quality with no anti-caking agents
  • Flexible volumes – Available from research amounts to scale-up quantities

General description

Magnesium sulfate is a magnesium salt with tocolytic ability. Its role to induce an analgesic effect during intraoperative and postoperative periods has been investigated. It is reported to prevent eclampsia. Its ability to remove water from water-miscible solvents by salting-out phase separation has been studied.

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

Clase de almacenamiento

13 - Non Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Lex W Doyle
Current opinion in pediatrics, 24(2), 154-159 (2012-01-10)
Antenatal magnesium sulfate may reduce the excessive rates of cerebral palsy in survivors of very preterm birth. There are five randomized controlled trials of magnesium sulfate therapy given to the mother prior to very preterm birth which have reported neurological
Lex W Doyle et al.
Obstetrics and gynecology, 113(6), 1327-1333 (2009-05-23)
To systematically review rates of neurologic outcomes reported in childhood for the preterm fetus exposed to antenatal magnesium sulfate. We searched the Cochrane Pregnancy and Childbirth Group's Trials Register, CENTRAL (The Cochrane Library 2008, Issue 3), relevant references from retrieved
Robert J Floor et al.
Chembiochem : a European journal of chemical biology, 15(11), 1660-1672 (2014-07-01)
We explored the use of a computational design framework for the stabilization of the haloalkane dehalogenase LinB. Energy calculations, disulfide bond design, molecular dynamics simulations, and rational inspection of mutant structures predicted many stabilizing mutations. Screening of these in small
Claire L O'Brien et al.
Gut, 63(10), 1596-1606 (2014-01-17)
Our aim was to determine whether or not specific microorganisms were transported selectively to lymph nodes in Crohn's disease (CD) by comparing node and mucosal microbial communities in patients and controls. We also sought evidence of dysbiosis and bacterial translocation.
Federica Belluti et al.
ChemMedChem, 9(2), 371-382 (2014-01-10)
A significant improvement in the treatment of trypanosomiases has been achieved with the recent development of nifurtimox-eflornithine combination therapy (NECT). As an alternative to drug combinations and as a means to overcome most of the antitrypanosomatid drug discovery challenges, a

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico